Infectious Diseases 2014-10 - Infectious Disease Alert - Oct 01, 2014

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Hospital Epidemiologist
Sequoia Hospital
Redwood City, CA

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Board Member and Associate Editor
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Philip R. Fischer, MD, DTM&H
Professor of Pediatrics,
Department of Pediatric and Adolescent Medicine,
Mayo Clinic, Rochester, MN. 

Hal B. Jenson, MD, FAAP
Dean, Western Michigan University Homer Stryker
M.D. School of Medicine,
Kalamazoo, MI


  • ID Grand Rounds - Stanford University Woman, 58, with Fever and Abdominal Pain
  • A Strategy for Early Discontinuation of Antibiotics in Febrile Infants
  • Dosing of Beta-Lactam Antibiotics in Critically Ill Patients Is Often Inadequate
  • Tapered antibiotics with kefir may be effective in recurrent C. difficile infection.
  • Treatment of Dengue – Failure of a Novel Agent
  • Out of Africa: Ebola Cases come to U.S.
  • Lab incidents divide scientists on research


  • Discuss the diagnosis and treatment of infectious diseases
  • Explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • Discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck; Updates author, Carol A. Kemper, MD, FACP, does research for Abbott Laboratories and Merck. Peer reviewer Timothy Jenkins, MD, and executive editor Gary Evans report no financial relationships to this field of study.

Authors Hal B. Jenson, MD, FAAP, Eric C. Walter, MD, MSc, and Philip R. Fischer, MD, DTM&H report no financial relationships in this field of study. 

Copyright 2014, AHC Media.